BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
March 25, 2024 08:45 ET
|
BioElectronics Corporation
96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation...
BioElectronics Corporation Announces the Publication of Pilot Study Results
February 23, 2024 08:30 ET
|
BioElectronics Corporation
Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Chairman Updates Investors
February 15, 2024 09:00 ET
|
BioElectronics Corporation
Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation...
BioElectronics’ Chairman Discusses Recent Clinical Research Findings
July 22, 2022 06:00 ET
|
BioElectronics Corporation
Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a...
BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts
April 19, 2021 07:00 ET
|
BioElectronics Corporation
FREDERICK, MD, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC PINK: BIEL) is pleased to report Q1 2021 revenue figures, the progress...
BioElectronics Chairman Outlines New Direction for Company
August 10, 2020 07:30 ET
|
BioElectronics Corporation
FREDERICK, MD, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), (www.bielcorp.com) today released a Chairman’s Letter to Shareholders written by Dr....
Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation
June 15, 2020 09:00 ET
|
BioElectronics Corporation
FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that...
BioElectronics Announces U.S. FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain
February 03, 2020 06:00 ET
|
BioElectronics Corporation
FREDERICK, MD, Feb. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
August 13, 2018 07:30 ET
|
BioElectronics Corporation
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
May 29, 2018 11:48 ET
|
BioElectronics Corporation
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....